CN120132004A - 基于活性的探针化合物、组合物及其使用方法 - Google Patents

基于活性的探针化合物、组合物及其使用方法 Download PDF

Info

Publication number
CN120132004A
CN120132004A CN202510298059.1A CN202510298059A CN120132004A CN 120132004 A CN120132004 A CN 120132004A CN 202510298059 A CN202510298059 A CN 202510298059A CN 120132004 A CN120132004 A CN 120132004A
Authority
CN
China
Prior art keywords
group
compound
compounds
probe
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202510298059.1A
Other languages
English (en)
Chinese (zh)
Inventor
马修·S·博焦
马蒂金·韦尔多斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of CN120132004A publication Critical patent/CN120132004A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
CN202510298059.1A 2013-03-15 2014-03-15 基于活性的探针化合物、组合物及其使用方法 Pending CN120132004A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361794296P 2013-03-15 2013-03-15
US61/794,296 2013-03-15
CN201480028287.7A CN105431546A (zh) 2013-03-15 2014-03-15 基于活性的探针化合物、组合物及其使用方法
PCT/US2014/029990 WO2014145257A2 (en) 2013-03-15 2014-03-15 Activity-based probe compounds, compositions, and methods of use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201480028287.7A Division CN105431546A (zh) 2013-03-15 2014-03-15 基于活性的探针化合物、组合物及其使用方法

Publications (1)

Publication Number Publication Date
CN120132004A true CN120132004A (zh) 2025-06-13

Family

ID=51538442

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202510298059.1A Pending CN120132004A (zh) 2013-03-15 2014-03-15 基于活性的探针化合物、组合物及其使用方法
CN201480028287.7A Pending CN105431546A (zh) 2013-03-15 2014-03-15 基于活性的探针化合物、组合物及其使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201480028287.7A Pending CN105431546A (zh) 2013-03-15 2014-03-15 基于活性的探针化合物、组合物及其使用方法

Country Status (7)

Country Link
US (4) US10100037B2 (cg-RX-API-DMAC7.html)
EP (2) EP4218829A3 (cg-RX-API-DMAC7.html)
JP (5) JP6490660B2 (cg-RX-API-DMAC7.html)
KR (1) KR102279618B1 (cg-RX-API-DMAC7.html)
CN (2) CN120132004A (cg-RX-API-DMAC7.html)
ES (1) ES2938225T3 (cg-RX-API-DMAC7.html)
WO (1) WO2014145257A2 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4218829A3 (en) * 2013-03-15 2023-08-16 The Board of Trustees of the Leland Stanford Junior University Activity-based probe compounds, compositions, and methods of use
EP3204352B1 (en) 2014-10-06 2020-07-01 Cortexyme, Inc. Inhibitors of lysine gingipain
CN107406872B (zh) * 2015-01-22 2023-03-28 里兰斯坦福初级大学理事会 用于标记动物组织的化合物、组合物及其应用
EP3374352A4 (en) 2015-11-09 2019-10-02 Cortexyme, Inc. GINGIPAINE ARGININE INHIBITORS
IL265389B1 (en) 2016-09-16 2026-07-01 Quince Therapeutics Inc Ketone compounds lysine inhibitors gingerapine, preparations containing them and uses thereof
WO2018071556A1 (en) 2016-10-11 2018-04-19 The Regents Of The University Of California Detection, identification, and purification of degradative and non-degradative enzymes in biological samples
CN116217656B (zh) * 2016-12-23 2026-05-08 里兰斯坦福初级大学理事会 基于活性的探针化合物、组合物及其使用方法
CN110678460A (zh) * 2017-03-30 2020-01-10 里兰斯坦福初级大学理事会 用于体内成像的蛋白酶激活的造影剂
WO2018200592A1 (en) 2017-04-24 2018-11-01 Regents Of The University Of California Biosynthesis of bioorthogonal amino acids
EP3717019A4 (en) * 2017-11-28 2021-09-22 Board of Regents of the University of Nebraska RADIOPHARMACEUTICALS AND METHOD OF USE THEREOF
WO2020028396A1 (en) 2018-07-30 2020-02-06 Georgetown University Chirality sensing with molecular click chemistry probes
US11860084B2 (en) 2018-09-11 2024-01-02 Georgetown University Quantitative auxiliary-free chirality sensing with a metal probe
CA3120758A1 (en) * 2018-12-20 2020-06-25 Takeda Pharmaceutical Company Limited Novel activity-based probes for neutrophil elastase and their use
CA3120756A1 (en) * 2018-12-20 2020-06-25 Takeda Pharmaceutical Company Limited Sulfoxonium ylide derivatives as probes for cysteine protease

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009124265A1 (en) * 2008-04-03 2009-10-08 The Board Of Trustees Of The Leland Stanford Junior University Probes for in vivo targeting of active cysteine proteases
WO2012118715A2 (en) * 2011-02-28 2012-09-07 The Board Of Trustees Of Leland Stanford Junior University Non-peptidic quenched fluorescent imaging probes

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
US5055451A (en) 1986-12-22 1991-10-08 Syntex Inc. Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
WO1996041638A1 (en) 1995-06-13 1996-12-27 Sanofi Winthrop, Inc. Calpain inhibitors for the treatment of neurodegenerative diseases
US5989823A (en) 1998-09-18 1999-11-23 Nexstar Pharmaceuticals, Inc. Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
AU2483599A (en) 1998-01-29 1999-08-16 Sepracor, Inc. Pharmaceutical uses of optically pure (-)-bupropion
US6197750B1 (en) 1998-07-02 2001-03-06 Idun Pharmaceuticals, Inc. C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
US6544951B2 (en) * 1998-07-02 2003-04-08 Idun Pharmaceuticals, Inc. C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
WO2000064988A1 (en) 1999-04-23 2000-11-02 Molecular Probes, Inc. Xanthene dyes and their application as luminescence quenching compounds
US7019129B1 (en) 2000-05-09 2006-03-28 Biosearch Technologies, Inc. Dark quenchers for donor-acceptor energy transfer
US20020052323A1 (en) * 2000-08-30 2002-05-02 Jinhai Wang Quinoline-(C=O)-(multiple amino acids)-leaving group compounds for pharmaceutical compositions and reagents
GB0112868D0 (en) 2001-05-25 2001-07-18 Secr Defence Detection system
US20050014160A1 (en) 2003-07-18 2005-01-20 Sriram Kumaraswamy Assays for protease enzyme activity
US8968700B2 (en) 2005-08-11 2015-03-03 The Board Of Trustees Of The Leland Stanford Junior University Imaging of protease activity in live cells using activity based probes
WO2012021800A2 (en) * 2010-08-13 2012-02-16 Banyan Biomarkers Caspase inhibitors as therapeutics for neural and organ injury and imaging
WO2014152389A1 (en) 2013-03-14 2014-09-25 Lumicell, Inc. Imaging agent for detection of diseased cells
EP4218829A3 (en) * 2013-03-15 2023-08-16 The Board of Trustees of the Leland Stanford Junior University Activity-based probe compounds, compositions, and methods of use
CN116217656B (zh) * 2016-12-23 2026-05-08 里兰斯坦福初级大学理事会 基于活性的探针化合物、组合物及其使用方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009124265A1 (en) * 2008-04-03 2009-10-08 The Board Of Trustees Of The Leland Stanford Junior University Probes for in vivo targeting of active cysteine proteases
WO2012118715A2 (en) * 2011-02-28 2012-09-07 The Board Of Trustees Of Leland Stanford Junior University Non-peptidic quenched fluorescent imaging probes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GALIA BLUM等: "Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes", NATURE CHEMICAL BIOLOGY, vol. 3, no. 10, 9 September 2007 (2007-09-09), pages 669 *
MARTIJN VERDOES等: "A non-peptidic cathepsin S activity-based probe for noninvasive optical imaging of tumor-associated macrophages", CHEM BIOL., vol. 19, no. 5, 25 May 2012 (2012-05-25), pages 619 - 628 *
MARTIJN VERDOES等: "An improved quenched fluorescent probe for imaging of cysteine cathepsin activity", J AM CHEM SOC., vol. 135, no. 39, 2 October 2013 (2013-10-02), pages 1 - 10, XP055287988, DOI: 10.1021/ja4056068 *
Q SHAO等: "Chemistry of Optical Imaging Probes", MOLECULAR IMAGING PROBES FOR CANCER RESEARCH, 31 December 2012 (2012-12-31), pages 432 - 433 *

Also Published As

Publication number Publication date
JP2025124721A (ja) 2025-08-26
US20230391750A1 (en) 2023-12-07
US20210284626A1 (en) 2021-09-16
WO2014145257A2 (en) 2014-09-18
US20160039792A1 (en) 2016-02-11
KR20150129004A (ko) 2015-11-18
EP4218829A2 (en) 2023-08-02
US11655236B2 (en) 2023-05-23
EP2971065B1 (en) 2022-12-14
US20190270722A1 (en) 2019-09-05
JP6490660B2 (ja) 2019-03-27
US10100037B2 (en) 2018-10-16
JP2016518341A (ja) 2016-06-23
JP7689753B2 (ja) 2025-06-09
KR102279618B1 (ko) 2021-07-20
EP2971065A2 (en) 2016-01-20
US10829477B2 (en) 2020-11-10
ES2938225T3 (es) 2023-04-05
JP2019081791A (ja) 2019-05-30
JP2021059606A (ja) 2021-04-15
WO2014145257A3 (en) 2014-12-31
EP2971065A4 (en) 2016-12-21
JP2023085423A (ja) 2023-06-20
CN105431546A (zh) 2016-03-23
EP4218829A3 (en) 2023-08-16

Similar Documents

Publication Publication Date Title
JP7689753B2 (ja) 活性に基づくプローブの化合物、組成物、および使用方法
JP7720102B2 (ja) 活性ベースのプローブ化合物、組成物、および使用方法
JP5015794B2 (ja) 蛍光造影剤

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination